(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-US...06 state prisoners and 1,538 federal prisoners wer...f Justice Statistics (BJS) in the Office of Justic...today. At yearend 2008, an estimated 5,672 inmates...down from 5,762 in 2007. In 2007, about 43 per 10,...
(Date:12/1/2009)...Could identify those who would benefit from liver ...UESDAY, Dec. 1 (HealthDay News) -- A CT scan of li...er may help predict overall survival after chemoth... (Avastin) to cytotoxic chemotherapy has been show...colorectal cancer and to produce better results in...
(Date:12/1/2009)... Practitioners of any med...anscription are breathing a sigh of relief this we...iPhone. The application, released over the holida...ranscribe voice recordings to do so quickly and se... (PRWEB) December 1, 2009 -- The...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /... and a global leader in the development and delive... for the medical, scientific and academic markets,...iversal Search, our first-to-market cross-platform...psychology lexicon, based on the American Psycholo...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNew...n of patient enrollment in the randomized clinical...ng Stent (Combo Stent). ,, A prospective, rando... E valuation of an ablu M inal sirolimus coat ...0 patients at up to 20 sites in Asia, Australia, E...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4